PO-32 Plasminogen activator inhibitor-1 4G/5G polymorphism in breast cancer

  • R. Palmirotta, P. Ferroni, A. Savonarola, F. Martini, F. Ciatti, A. Laudisi, E. Fossile, G. Del Monte, F. Guadagni, M. Roselli
  • Thrombosis Research, January 2007, Elsevier
  • DOI: 10.1016/s0049-3848(07)70185-8

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: MD, PhD Raffaele Palmirotta